A paper published in the journal Science on August 8 suggests that it may be possible to speed up the drug discovery process.

Health insurer Cigna Corp. launched a program aimed at ensuring some diabetes patients pay no more than $25 for a 30-day supply of insulin in the wake of heightened public scrutiny over soaring prices of the life-saving drug.